MAPT and Alzheimer disease: Advances in PET scans to detect Tau [5], the other hallmark protein implicated in AD along with beta-amyloid [3], could significantly enhance detection and monitoring of neuropathological changes in the brain in both pre- and post-symptomatic cases.